Welcome to LookChem.com Sign In|Join Free

CAS

  • or

888720-29-4

Post Buying Request

888720-29-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

888720-29-4 Usage

Uses

4-Chloropyrrolo[1,2-f][1,2,4]triazine is a pyrrolotriazine derivative used in the preparation of kinase inhibitors for treating cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 888720-29-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,8,7,2 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 888720-29:
(8*8)+(7*8)+(6*8)+(5*7)+(4*2)+(3*0)+(2*2)+(1*9)=224
224 % 10 = 4
So 888720-29-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H3ClN4/c6-4-5-7-1-2-10(5)9-3-8-4/h1-3H

888720-29-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloropyrrolo[1,2-f][1,2,4]triazine

1.2 Other means of identification

Product number -
Other names 4-chloropyrrolo[2,1-f][1,2,4]triazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:888720-29-4 SDS

888720-29-4Relevant articles and documents

Deaminative chlorination of aminoheterocycles

Ghiazza, Clément,Faber, Teresa,Gómez-Palomino, Alejandro,Cornella, Josep

, p. 78 - 84 (2021/12/23)

Selective modification of heteroatom-containing aromatic structures is in high demand as it permits rapid evaluation of molecular complexity in advanced intermediates. Inspired by the selectivity of deaminases in nature, herein we present a simple methodology that enables the NH2 groups in aminoheterocycles to be conceived as masked modification handles. With the aid of a simple pyrylium reagent and a cheap chloride source, C(sp2)?NH2 can be converted into C(sp2)?Cl bonds. The method is characterized by its wide functional group tolerance and substrate scope, allowing the modification of >20 different classes of heteroaromatic motifs (five- and six-membered heterocycles), bearing numerous sensitive motifs. The facile conversion of NH2 into Cl in a late-stage fashion enables practitioners to apply Sandmeyer- and Vilsmeier-type transforms without the burden of explosive and unsafe diazonium salts, stoichiometric transition metals or highly oxidizing and unselective chlorinating agents. [Figure not available: see fulltext.]

Novel compound for preparing key intermediate of remdesivir and preparation method thereof

-

Paragraph 0022, (2020/06/24)

The invention relates to a novel compound II used for synthesizing a key intermediate of remdesivir and a preparation method thereof. The preparation method of the compound II comprises the followingsteps: (a) halogenating 4-X-pyrrole[2,1-f][1,2,4]triazine as shown in a formula (V) to obtain 4-X-7-halogenated-pyrrole[2,1-f][1,2,4]triazine as shown in a formula (IV); (b) adding magnesium or alkylmagnesium halide to react with a ribose lactone derivative shown in the formula (VI) to generate glycosylate shown in the formula (III); and (c) converting hydroxyl into cyano in a proper solvent by the glycosylate (III) under the action of a cyaniding agent, a Lewis acid and a Bronsted acid to obtain the compound II. The prepared compound can be used for generating a key intermediate I required in synthesis of remdesivir through an ammoniation reaction. The invention provides a new compound II and a process route which is different from the prior art, is high in reaction selectivity and can be used for preparing the remdesivir key intermediate in batches.

BICYCLIC ETHER O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS

-

Paragraph 00232, (2020/08/22)

Described herein are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables Ar, X, R1, R3, R 4, Y1, Y2, n and p are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 888720-29-4